The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the diuretics that were provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since (b)(6) 2014.As part of the review, it was determined that the instrument's last service prior to the event was on (b)(6) 2019.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint category pulmonary edema.No trends were detected for this complaint category.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: pulmonary edema.(b)(4).(b)(6).
|
The territory manager reported by email that an extracorporeal photopheresis (ecp) patient experienced pulmonary edema following a treatment procedure.The patient's physician confirmed that the patient experienced pulmonary edema 30 minutes after the successful completion of their seventh ecp treatment procedure.The physician stated that a clinical assessment and x-ray confirmed the patient's pulmonary edema.The physician reported that the patient was subsequently treated with diuretics.The physician stated that the patient was now stable.The physician reported that the patient was already in the hospital due their pre-existing kidney and heart failure, which occurred seven months after the patient's allogeneic haematopoietic stem cell transplantation.The physician stated that the patient's ecp treatment schedule was two treatments the first week, three treatments the next week, and then two more treatments the following week.The physician reported that the hyperhydration and pulmonary edema experienced by this heart and kidney failure patient was most probably due to their ecp treatment.No product was returned for investigation.
|